SOUTH SAN FRANCISCO, Calif., May 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Company will present at two upcoming investor conferences.
Dan Swisher, Chief Executive Officer of Sunesis, will present at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14th at 3:00 PM Pacific Time at the Encore at the Wynn in Las Vegas.
Eric Bjerkholt, Executive Vice President, Corporate Development and Finance, Chief Financial Officer at Sunesis, will present at the UBS Global Healthcare Conference on Tuesday, May 21st at 12:30 PM Eastern Time at the Sheraton Hotel in New York City.
A live webcast of the presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the presentation.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
CONTACT: Investor and Media Inquiries: David Pitts Argot Partners 212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc. 650-266-3717
Source:Sunesis Pharmaceuticals, Inc.